HIGH

10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case.

During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.

Quick Facts at a Glance

Recall Date
January 27, 2026
Hazard Level
HIGH
Brand
Becton Dickinson &
Geographic Scope
1 states

Hazard Information

During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Becton Dickinson & Company or your healthcare provider for instructions. Notification method: E-Mail

Get instant alerts for Becton Dickinson & recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Full Description

10mL Non-Sterile BD Luer-Lok Tip Syringe Only. Catalog Number: 301029. 850 bulk non-sterile units per case.. Reason: During the bulk packaging process, some Luer Slip syringes were incorrectly included in a batch designated for Luer Lok syringes.. Classification: Class II. Quantity: 204,000 units. Distribution: US Nationwide distribution in the states of California and Texas.

View Original Recall on FDA - Medical Devices

Browse More Recalls

More from FDA_DEVICEHealth & Personal CareMedical Devices

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: How to Get Refunds and Replacements

Want to Know First?

Get instant alerts for recalls that affect you. Free forever.

Product Classification

Product Details

Model Numbers
Catalog Number: 301029.
UDI-DI: N/A. Lot Number: 5268614. Expiration Date: 08/31/2030.
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

CRITICAL

Massive Eye Drop Recall Hits CVS, Walgreens, Kroger — 8 Products Never Tested for Sterility (2026)

Millions of eye drop bottles sold at CVS, Walgreens, Kroger, and other major pharmacies may not be sterile. K.C. Pharmaceuticals of Pomona, California never verified that eight of its over-the-counter eye drop products met sterility standards, the FDA warned. A nearly identical manufacturing failure in 2023 left patients blind, cost others their eyes, and killed at least three people. Consumers should stop using the products and return them for a full refund.

CVS Health
Nonsterile eye
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.

OCTREOTIDE ACETATE
Lack of
Read more
HIGH

Straumann USA Recalls 13 Custom Abutment Ti RC for TAN Material Mix-Up (2026)

Straumann USA recalled 13 Custom Abutment Ti RC units distributed worldwide, including the United States and Canada. A TAN material was misidentified as Titanium Ti Gr4 D during manufacturing, causing RC Titanium abutments to be made from TAN material. Clinics and patients should stop using the devices immediately and follow recall instructions from Straumann USA or their healthcare providers.

Straumann USA
A material
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)

Teva Pharmaceuticals USA recalled 19,869 cartons of Octreotide Acetate for Injectable Suspension nationwide in the United States after FDA inspection flagged lack of assurance of sterility at the contract manufacturer. The FDA cited quality system deficiencies at Pharmathen International S.A. in Greece. Healthcare providers and patients should stop using the product immediately and contact Teva or

OCTREOTIDE ACETATE
Lack of
Read more
HIGH

Teva Octreotide Acetate Injectable Suspension Recall Expanded in 2026 for Sterility Concerns

Teva Pharmaceuticals recalled 1,897 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the USA after an FDA inspection flagged sterility concerns. The recall is due to lack of assurance of sterility from the contract manufacturer. Consumers and healthcare providers should stop using the product immediately and contact Teva for guidance.

OCTREOTIDE ACETATE
Lack of
Read more